Key Takeaways
- H1 revenue up 11%, but enterprise stumbled: Consumer business held firm against industry degrowth, while enterprise growth was dampened by non-closure of key government orders and a sales pivot still in progress.
- Margins collapsed to sub-10% by design: The drop from 30%+ is the result of expensing all R&D investments into new products like Zero Trust and XDR, compounded by consumer business headwinds.
- AntiFraud.ai is a bet on a new category: The first-of-its-kind consumer fraud protection app has launched with no current competition, already generating revenue, and management is framing it as a mission-driven expansion beyond antivirus.
- Data privacy law is the near-term catalyst: Enforcement guidance is expected this quarter, with management anticipating a pipeline and closure boost in Q4 and Q1, based on a 5–7% investment uptick seen after similar GDPR-style regulations.
- What to watch next quarter: Whether the enterprise sales pivot to mid-market starts converting pipeline into closed deals, any early traction metrics for AntiFraud.ai, and the actual timing of the data privacy enforcement guidance.
Enterprise Business: The Pivot and the Miss
- Government orders stalled growth: The enterprise segment had a sluggish quarter primarily because key government orders did not close, exposing the lumpiness of a business still transitioning its sales motion.
- Sales pivot is a work in progress: The company is moving from a micro/SMB focus to targeting the mid-market and the lower end of large enterprises, competing against top global companies, and is still building out the leadership and mid-management sales team to execute this.
- Initial wins prove the concept: New contracts include modernizing the cybersecurity stack for India's largest logistics company, solving a remote access problem for a leading media firm via a zero-trust solution, and replacing an incumbent vendor at a healthcare company.
- Cloud mix is shifting: The enterprise cloud mix has moved from 17% in FY23 to 28% currently, a metric management is now disclosing as a lead indicator, though revenue recognition follows product EULAs, not cloud consumption.
- Regulatory tailwind is real but pending: Growing breaches and new SEBI cybersecurity guidance are heightening demand, and the data privacy act's enforcement guidance, expected in Q3, is anticipated to positively impact closures in Q4 and Q1 next year.
Salvi: "we are the only full stack cybersecurity company from India"
The Margin Reset: R&D Investment Over Profit
- Margins sacrificed for a product build-out: Operating margins have fallen from over 30% to below 10% because the company is channeling margins into R&D for new technologies, including Zero Trust Network Access, extended detection and response, and data privacy products.
- All investment is expensed immediately: The company does not capitalize any R&D costs, choosing to expense everything in the year it is incurred, which amplifies the reported margin compression but reflects a conservative accounting stance.
- Core R&D team is largely built: The foundational R&D team is already in place, augmented with specialized external talent, so management expects R&D costs not to grow significantly from here, with only incremental skill additions needed.
- Product lifecycle dictates returns: Mature, core products still deliver significantly higher returns, while newly introduced products are on a break-even path, and a third horizon of products is now in development with board approval.
- Consumer business margins are stable: Despite market headwinds, the consumer business remains a mature, well-oiled model with stable margins, though management flagged that some work is needed on collections in the coming quarters.
Salvi: "We don't see them as eating away the profit. We see them as investment. We don't capitalize. We basically expense out all our investments in the same year books."
AntiFraud.ai: A New Category Bet
- A first-of-its-kind launch: The company has launched AntiFraud.ai, a direct-to-consumer solution designed to protect users from fraud calls and fraudulent attempts on phones and computers, a category management claims has no current competition in India.
- Revenue has already started: The product is shipping and available for download on the Play Store and App Store, and it began generating revenue this quarter, though management declined to share any medium-term revenue targets.
- Go-to-market is scaling nationally: The plan involves India-wide advertising campaigns, channel partners, and alliances to drive adoption, with the company leveraging social media and micro-influencers for consumer awareness, a tactic that has worked for its core business.
- A mission-driven expansion: Management argues the company should be seen not as an antivirus firm but as a consumer protection business, and that the migration of consumer threats from viruses to fraud makes this launch a responsibility, not just an opportunity.
Salvi: "you should look at Quick Heal, not as an antivirus company. We are in the business of protecting end consumers. Now, if that is our mission, then we need to recognize that when you know the issues have moved from antivirus to fraud, it is our responsibility to do something about that"
Consumer Business: Resilience in a Declining Market
- Outperforming a shrinking market: The consumer antivirus market faces demand headwinds and declining overall adoption, but Quick Heal has held its ground as a market leader, maintaining respectable growth while the industry degrows.
- Product quality is a moat: Quick Heal Total Security scored 17.5 out of 18 in AV tests, and its endpoint security solution received a perfect 18 out of 18, featuring as a top product and reinforcing the brand's technical credibility with consumers.
- Collections need attention: While the consumer business model remains stable and well-oiled, management noted that improving collections in the consumer section is a focus over the next six months.
- Product mix is diversifying: Seven years ago, the business was 100% consumer antivirus; today, the core is roughly 85%, with new products like AntiFraud.ai expected to gain momentum and increase their revenue share over time.
Product Engine and Competitive Moat
- Patents and certifications are stacking up: The company received another patent this quarter, taking its total to nine, while Seqrite XDR was awarded AV-Test approved advanced endpoint detection and response certification.
- New enterprise solutions are being built on proprietary research: A secure web gateway, cloud security access broker, malware analysis platform, and threat intelligence platform have all been developed on Seqrite labs' research, expanding the addressable enterprise stack.
- Horizon 3 investment is now approved: The board has approved investment in the next generation of products, and work has already started, signaling a long-term commitment to the R&D-heavy strategy.
- The long game on profitability: Management pointed out that top global cybersecurity product companies took 10 to 15 years to break even, with some still unprofitable, framing Quick Heal's current investment phase as consistent with industry norms for building a full-stack product company.
Salvi: "The top cybersecurity product companies in the world, which are doing well right now have would have taken anything between 10 to 15 years or to break even and there are some which are yet to break even right in spite of that."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Collections improvement | Focus on getting consumer business collections back on track | Next six months |
| Data privacy enforcement impact | Positive impact on pipeline and closures expected, based on 5–7% investment uptick pattern seen after GDPR | Q4 FY25 and Q1 FY26 |
| R&D cost trajectory | R&D cost not expected to grow significantly; core team already in place, only incremental skill additions needed | Ongoing |
| Enterprise sales pivot | Transition from micro/SMB to mid-market and lower-end large enterprises, with sales team being strengthened | Work in progress, no end date |
| New product monetization | Clear path and board commitment on how to break even each product category | No timeline given |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Consolidated revenue | ₹73.5 cr, +5% QoQ, -6% YoY |
| H1 FY25 revenue growth | 11% |
| H1 FY25 EBITDA | ₹5.7 cr, vs -₹4.1 cr in H1 FY24 |
| H1 FY25 EBITDA growth | 238% |
| PAT | ₹4.1 cr |
| Total expenses | ₹71 cr, maintained steady |
| Consumer vs enterprise split | 62% / 38% |
| Core products revenue share | 85–90% of total revenue |
| New products revenue share | 10–15% of total revenue, introduced in last 1.5 years |
| Enterprise business on cloud | 28%, up from 17% in FY23 |
| Consumer AV market share | 33–35% in India |
| Seqrite XDR certification | AV-Test approved advanced endpoint detection and response |
| Endpoint security AV-Test score | 18 out of 18, perfect score |
| Quick Heal Total Security AV-Test score | 17.5 out of 18 |
| Total patents | 9 |